Request for Proposals - Supply of Haemophilia Treatments

Details

Tender Closed
RFx ID :	19909881
Tender Name :	Request for Proposals - Supply of Haemophilia Treatments
Reference # :	A1140838
Open Date :	Monday, 23 July 2018 11:30 AM (Pacific/Auckland UTC+12:00)
Close Date  :	Monday, 20 August 2018 5:00 PM (Pacific/Auckland UTC+12:00)
Tender Type :	Request for Proposals (RFP)
Tender Coverage :	Sole Agency  [?]
Categories :	51000000 - Drugs and Pharmaceutical Products
Regions:	New Zealand
Exemption Reason :	None
Required Pre-qualifications :	None
Contact :	Josh Wiles josh.wiles@pharmac.govt.nz
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :

PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant Factor VIIa and FEIBA) in New Zealand.

This request for proposals (RFP) letter incorporates the following schedules:

· Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5.00 p.m. on 20 August 2018.

If you have any questions about this RFP, please post these on GETS. Responses to all questions will be published on GETS.

We look forward to receiving your proposal.

This tender has been awarded to:

• Bayer Limited
• Bioverativ Australia
• Novo Nordisk Pharmaceuticals Pty Ltd
• Pfizer New Zealand
• Shire New Zealand

Further Award Information:
Agency Name and Address:

PHARMAC, 40 Mercer Street, Wellington

This tender has been awarded to:

• Sanofi-Aventis New Zealand Limited

• Shire New Zealand Ltd

• Novo Nordisk Pharmaceuticals Ltd

• Bayer New Zealand Ltd

• Pfizer New Zealand Limited


Further Award Information:

Address of Successful Tenderer(s):

• Agility CIS Tower, Level 8, 56 Cawley Street, Ellerslie, Auckland 1051

• Level 10, Zurich House, 21 Queen Street, Auckland 1010

• PO BOX 7586, Baulkham Hills Business Centre, NSW 2153, Australia

• 3 Argus Pl, Hillcrest, Auckland 0627

• 8 Grafton Rd, Grafton, Auckland

Description of Services: Haemophilia Treatments

Date the contract/s was awarded: 28/02/2019.

Term of contract/s (including rights of renewals): 3+1+1

Type of process used: Open

Estimated cost of the procurement: $25M-$50M

Type of Procurement process used: Open

Was there an exemption used: No

Award Date: Friday, 21 June 2019 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Monday, 19 November 2018 5:30 AM (Pacific/Auckland UTC+13:00)